Immune Checkpoint Therapy–Induced Lupus Nephritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune Checkpoint Therapy–Induced Lupus Nephritis

Published:2024-05 Issue:5 Volume:9 Page:1534-1537
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Hanif Imran Humza,Abdelrahim Saifudeen,Al Shaarani Majd,Lu Huifang,Ahmad Raisa,Goswami Sangeeta,Abudayyeh Ala

Funder

National Institutes of Health

University of Texas MD Anderson Cancer Center

National Cancer Institute

Publisher

Elsevier BV

Reference9 articles.

1. Profiling preexisting antibodies in patients treated with anti-PD-1 therapy for advanced non-small cell lung cancer;Toi;JAMA Oncol,2019

2. A systematic review of immune checkpoint inhibitor-associated glomerular disease;Kitchlu;Kidney Int Rep,2021

3. Immune checkpoint inhibitor-associated sarcoidosis reaction in the kidney: case report;Charkviani;Kidney Med,2023

4. Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies;Sakakida;Clin Transl Oncol,2020

5. Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: a prospective longitudinal pan-cancer study;Barth;Cancer Med,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydralazine/pembrolizumab;Reactions Weekly;2024-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP